Delivery Order SPE2DB20D3303-SPE2DB25FA2WG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lacosamide 10 mg/ml Solution in a 200ml quantity, with a ceiling value of $2,681.84 and an ultimate completion date of August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Lacosamide 10 mg/ml solution in a 200 ml quantity, with a contract ceiling value of $1,051.54. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for ultimate completion by August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lacosamide 10 mg/mL Solution in a 200 mL quantity, with a ceiling value of $1,296.57. This competitively awarded, firm fixed-price contract was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The award carries no set-aside designation, indicating it was competed among all eligible vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency Troop Support Medical awarded a $207,180 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 milliliters of the pharmaceutical product lacosamide 10 mg/ml solution. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 3, 2023 through August 4, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle...
- The Defense Logistics Agency Troop Support Medical awarded a $176,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 milliliters of the pharmaceutical product lacosamide 10 mg/ml solution. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 31, 2023 through August 1, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of lacosamide 10 mg/ml solution in 200 ml containers. The contract has a firm-fixed price of $2,372.32 and an ultimate completion date of September 9, 2024. The contract was not set aside for any special category of businesses. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is part of a larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency Troop Support Medical awarded a $138,120 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200ml bottles of the pharmaceutical product lacosamide 10mg/ml solution. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance for this delivery order is one day, from June 26, 2023 through June 27, 2023. No set aside designation or subcontracting details were provided. This...
- The Defense Logistics Agency Troop Support Medical awarded a $298,540 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60,000 units of 150 mg lacosamide tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 28, 2023 through July 31, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by...
- The Defense Logistics Agency awarded a $414,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 milliliters of the pharmaceutical product Lacosamide 10 mg/ml solution. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 13, 2023 through July 14, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any broader...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lacosamide 200 mg/20 ml vials. The contract has a firm fixed price of $1,946.95 and an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2WGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lacosamide 10 mg/mL solution in 200 mL quantities, with a ceiling value of $1,351.98 and an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a prime contractor for this global pharmaceutical support agreement, AmerisourceBergen Drug Corp supplies a broad range of medications and medical supplies to support military healthcare programs and other federal healthcare systems. Lacosamide is an anti-epileptic medication, consistent with AmerisourceBergen Drug Corp's portfolio of neurological treatments supplied through its federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/21/25 |